# Dapagliflozin in the Treatment of Heart Failure

> **NCT05727423** · — · UNKNOWN · sponsor: **Helwan University** · enrollment: 45 (actual)

## Conditions studied

- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05727423
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2024-01-28
- **Final completion:** 2024-02-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727423, "Dapagliflozin in the Treatment of Heart Failure". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05727423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*